Progress in Ulcerative Colitis with Spleen and Kidney Yang Deficiency Type

Author:

Wang Lu,Li Yi

Abstract

Ulcerative colitis is a chronic, non-specific, recurrent and inflammatory disease mainly involving the colorectal mucosa. In recent years, its incidence has been on the rise worldwide, and it has gradually become a common disease of the digestive system and difficult to treat. Because its pathogenesis is not clear, there is no specific drug in treatment. Compared with the limitations of western medicine treatment, traditional Chinese medicine has the advantages of definite curative effect in treatment, small side effects and low recurrence rate. In the TCM syndrome differentiation, spleen and kidney Yang deficiency is the most common. This paper summarizes the TCM treatment research of spleen and kidney Yang deficiency ulcerative colitis in recent years, which provides new ideas for the clinical research and diagnosis and treatment of this disease.

Publisher

Century Science Publishing Co

Reference43 articles.

1. Kim YS, Kim YH, Kim JS, et al. Long-term outcomes of cytome galovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study [J]. Gut Liver, 2014, 08(06):643.

2. Zhang Shengsheng, Zhao Luqing. Review on the progress of TCM in the treatment of ulcerative colitis [J]. Beijing Traditional Chinese Medicine, 2022, 41 (9): 944-950.

3. He Yequn, Liu Yipin. Progress in the medical treatment of ulcerative colitis [J]. International Medical and Health Guide, 2021, 27 (18): 2831-2835.

4. Shi Rui, Li Junxiang, Shen Hong, et al. Expert consensus of TCM diagnosis and treatment of ulcerative colitis (2023) [J]. Chinese Journal of Traditional Chinese Medicine, 2024, 39 (01): 288-296.

5. Wang flood quantity. Based on metabolomics study on the mechanism of aconite pill in improving ulcerative colitis with spleen and kidney Yang deficiency [D]. Chengdu University of Traditional Chinese Medicine, 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3